Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 3Not yet recruiting 1

Sponsor Class

INDUSTRY 3OTHER 1

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Breast 4

Conditions

Breast Neoplasms 13138Triple Negative Breast Neoplasms 1150Neoplasms 750Ovarian Neoplasms 680Neoplasm Metastasis 590Lung Neoplasms 582Colorectal Neoplasms 581Prostatic Neoplasms 560Carcinoma, Non-Small-Cell Lung 536Pancreatic Neoplasms 380Melanoma 366Stomach Neoplasms 350Colonic Neoplasms 330Motor Activity 285Breast Neoplasms, Male 285Carcinoma, Intraductal, Noninfiltrating 277Uterine Cervical Neoplasms 267Head and Neck Neoplasms 266Endometrial Neoplasms 256Carcinoma, Renal Cell 216Sarcoma 204Urinary Bladder Neoplasms 192Squamous Cell Carcinoma of Head and Neck 192Lymphedema 190Esophageal Neoplasms 189Breast Carcinoma In Situ 189Brain Neoplasms 183Fatigue 166Carcinoma, Ovarian Epithelial 151Small Cell Lung Carcinoma 148

Interventions

exemestane 1entinostat 1Mammography 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Mammary Neoplasms, Animal × Breast × Clear all
NCT06251544 2026-03-04

TRAIL-R2 and HER2 Bi-Specific Chimeric Antigen Receptor (CAR) T Cells for the Treatment of Metastatic Breast Cancer

Baylor College of Medicine

Phase 1 Not yet recruiting
27 enrolled
Breast

Breast Neoplasms, Mammary Neoplasms, Animal

NCT00676663 2022-05-11

ENCORE301

Syndax Pharmaceuticals

Phase 2 Completed
130 enrolled 18 charts
Breast

Breast Neoplasms, Mammary Neoplasms, Animal

NCT02977247 2021-09-05

SV PCC ARM2

Delphinus Medical Technologies, Inc.

Completed
1,150 enrolled
Breast

Breast Neoplasms, Mammary Neoplasms, Animal

NCT03257839 2021-09-05

SV PCC ARM1

Delphinus Medical Technologies, Inc.

Completed
7,409 enrolled
Breast

Breast Neoplasms, Mammary Neoplasms, Animal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡